In its advice published in December, PBAC noted there was a "significant risk" that people who did not meet the two criteria and particularly those who met one threshold but not the other would seek access to the subsidised drugs and therefore that a "risk sharing arrangement" with the company would be needed to manage the cost to the government
But once the scale moves, a new question emerges, what happens next
In this context, micro-immunotherapy can be a valuable therapeutic tool for health professionals in addressing various dermatological conditions, such as acute or recurrent herpes
You can message your care team anytime between visits, and if youre unhappy with your provider, you can switch directly in the patient portal
Hypoglycemia risk with tirzepatide monotherapy is low due to its glucose-dependent mechanism of action
Eating every 34 hours can also prevent energy dips and hunger spikes